Package 69639-101-04

Brand: akynzeo

Generic: netupitant and palonosetron
NDC Package

Package Facts

Identity

Package NDC 69639-101-04
Digits Only 6963910104
Product NDC 69639-101
Description

2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2014-10-13
Brand akynzeo
Generic netupitant and palonosetron
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4a6ba486-f8be-41a3-847e-429548867605", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185503", "N0000190113", "N0000175817", "N0000175818"], "upc": ["0369639101046"], "unii": ["T672P80L2S", "7732P08TIR", "23310D4I19", "5D06587D6R"], "rxcui": ["1552343", "1552349", "2044429", "2044431", "2374366", "2374368"], "spl_set_id": ["8e47618e-af46-4d82-94e8-1507c042252d"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]", "Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Helsinn Therapeutics (U.S.), Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (69639-101-01)  / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "69639-101-01", "marketing_start_date": "20141013"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (69639-101-04)  / 2 CAPSULE in 1 BLISTER PACK", "package_ndc": "69639-101-04", "marketing_start_date": "20141013"}], "brand_name": "AKYNZEO", "product_id": "69639-101_4a6ba486-f8be-41a3-847e-429548867605", "dosage_form": "CAPSULE", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "69639-101", "generic_name": "Netupitant and Palonosetron", "labeler_name": "Helsinn Therapeutics (U.S.), Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AKYNZEO", "active_ingredients": [{"name": "NETUPITANT", "strength": "300 mg/1"}, {"name": "PALONOSETRON", "strength": ".5 mg/1"}], "application_number": "NDA205718", "marketing_category": "NDA", "marketing_start_date": "20141013", "listing_expiration_date": "20271231"}